Abstract
Suboptimal vitamin D (vitD) status and reduced lean body mass are highly prevalent in pediatric inflammatory bowel diseases (IBD). The study objective was to determine sarcopenia prevalence and associations with vitD status in newly diagnosed pediatric IBD. Children with Crohnâs disease (CD; nâ=â58) and ulcerative colitis (UC; nâ=â27) were included. Primary outcomes included body composition (total/regional/percent fat mass (FM), fat-free mass (FFM), skeletal muscle mass (SMM)), and vitD status (serum 25(OH)D). Sarcopenia was defined as SMM-zâ<ââ2. Additional variables measured included serum CRP, ESR, anthropometric, Pediatric Crohnâs Disease Activity Index (PCDAI), and the Pediatric Ulcerative Colitis Disease Activity index (PUCAI). Sarcopenia and suboptimal 25(OH)D levels (<â50 nmol/l) were found in 23.5% (nâ=â20) and 52% (nâ=â44) of children, respectively. Younger children (<â13 years) with CD with suboptimal 25(OH)vitD (<â50ânmol/l) had the greatest frequency of sarcopenia (57.1%) (pâ=â0.004). Sarcopenia was prevalent in newly diagnosed, young children with CD with vitD deficiency.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gupta N, Bostrom AG, Kirschner BS, Cohen SA, Abramson O, Ferry GD, et al. Presentation and disease course in early- compared to later-onset pediatric Crohnâs disease. Am J Gastroenterol. 2008;103:2092â2098.
Thangarajah D, Hyde MJ, Konteti VK, Santhakumaran S, Frost G, Fell JM. Systematic review: Body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:142â157.
Subramaniam K, Fallon K, Ruut T, Lane D, McKay R, Shadbolt B, et al. Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohnâs disease. Aliment Pharmacol Ther. 2015;41:419â428.
Pappa H. Vitamin D deficiency and supplementation in patients with IBD. Gastroenterol Hepatol (N Y). 2014;10:127â129.
Stoian CA, Lyon M, Cox RG, Stephure DK, Mah JK. Vitamin D concentrations among healthy children in Calgary, Alberta. Paediatr Child Health. 2011;16:82â86.
Almurdhi MM, Reeves ND, Bowling FL, Boulton AJ, Jeziorska M, Malik RA. Distal lower limb strength is reduced in subjects with impaired glucose tolerance and is related to elevated intramuscular fat level and vitamin D deficiency. Diabet Med. 2017;34:356â363.
Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99:4336â4345.
Rodd C, Metzger DL, Sharma A. Extending World Health Organization weight-for-age reference curves to older children. BMC Pediatr. 2014;14:32.
Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, et al. Mathematical weighting of the pediatric Crohnâs disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis. 2012;18:55â62.
Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423â432.
Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314â1321.
Webber CE, Barr RD. Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents. J Cachex- Sarcopenia Muscle. 2012;3:25â29.
Kim J, Shen W, Gallagher D, Jones A Jr., Wang Z, Wang J, et al. Total-body skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in children and adolescents. Am J Clin Nutr. 2006;84:1014â1020.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911â1930.
Bryant RV, Ooi S, Schultz CG, Goess C, Grafton R, Hughes J, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(9):895â906.
Pojednic RM, Ceglia L, Lichtenstein AH, Dawson-Hughes B, Fielding RA. Vitamin D receptor protein is associated with interleukin-6 in human skeletal muscle. Endocrine. 2015;49:512â520.
Pojednic RM, Ceglia L, Olsson K, Gustafsson T, Lichtenstein AH, Dawson-Hughes B, et al. Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells. Calcif Tissue Int. 2015;96:256â263.
Proctor DN, OâBrien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol. 1999;277(3 Pt 1):E489âE495.
Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res. 2016;36:201â213.
Acknowledgments
Funding for this cohort was provided by Stollery Childrenâs Hospital foundation through the Women and Childrenâs Research Institute and the Canadian Children IBD Network: a joint partnership of the CH.I.L.D. Foundation and CIHR is gratefully acknowledged. KRM was funded by the Stollery Childrenâs Hospital Foundation/Lois Hole Hospital for Women through the Women and Childrenâs Health Research Institute Graduate Scholarship and the Wirtanen Graduate Scholarship (Alberta Diabetes Institute).
Author contributions
DM: study design, data analysis/interpretation, and writing/review/final approval of manuscript. MC: study design, data collection/interpretation, and writing/review manuscript. EW: study design, data collection/interpretation, and review/final approval manuscript. PM, KM, JW, CK and JW responsible for study design and data collection/review/final approval of manuscript. MC and JW: data interpretation and review/final approved manuscript. JMT: data analysis/interpretation and review/final approval manuscript. HQ: study design, data collection, data analysis/interpretation, and writing/review/final approval manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Mager, D.R., Carroll, M.W., Wine, E. et al. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr 72, 623â626 (2018). https://doi.org/10.1038/s41430-018-0105-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-018-0105-2
This article is cited by
-
Growth and physical development of children at apparent risk of sarcopenia
Pediatric Research (2024)
-
Nutritional status of pediatric patients with inflammatory bowel diseases is related to disease duration and clinical picture at diagnosis
Scientific Reports (2023)